Showing results (351-360 of 520) with videos related to

Sort By:
Pageof 52
HIV Medicine|December 15, 2018
High-risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV-positive men who have sex with menErm Pool, A Winston, E Bagkeris, et al.
Diabetes Care|February 13, 2008
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyStephane De Wit, Caroline A Sabin, Rainer Weber, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2021
Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in NigeriaKate El Bouzidi, Rawlings P Datir, Vivian Kwaghe, et al.
The Journal of Infectious Diseases|January 12, 2024
Distinct Inflammatory Phenotypes Are Associated With Subclinical and Clinical Cardiovascular Disease in People With Human Immunodeficiency VirusPadraig McGettrick, Willard Tinago, Julie O'Brien, et al.
Obesity Research & Clinical Practice|August 26, 2023
Change in adiposity is associated with change in glycoprotein acetyls but not hsCRP in adolescents with severe obesityToby Mansell, Siroon Bekkering, Danielle Longmore, et al.
International Journal of Obesity (2005)|January 6, 2022
Decreasing severity of obesity from early to late adolescence and young adulthood associates with longitudinal metabolomic changes implicated in lower cardiometabolic disease riskToby Mansell, Costan G Magnussen, Joel Nuotio, et al.
Elife|August 13, 2021
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapyAlexander O Pasternak, Jelmer Vroom, Neeltje A Kootstra, et al.
The Journal of Pediatrics|November 24, 2019
Age-Specific Estimates and Comparisons of Youth Tri-Ponderal Mass Index and Body Mass Index in Predicting Adult Obesity-Related OutcomesFeitong Wu, Marie-Jeanne Buscot, Harri Niinikoski, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
The Journal of Infectious Diseases|August 4, 2016
Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D StudyLene Ryom, Jens D Lundgren, Mike Ross, et al.
Pageof 52